For over a century, acute 'post-streptococcal glomerulonephritis'(APSGN) was the
prototypical form of bacterial infection-associated glomerulonephritis, typically occurring …

Importance The current standard induction therapy for antineutrophil cytoplasm antibody
(ANCA)–associated vasculitis is the combination of high-dose glucocorticoids and …

Objectives A prospective randomised trial to compare two different durations of maintenance
immunosuppressive therapy for the prevention of relapse in anti-neutrophil cytoplasmic …

The substantial decline in the Pneumocystis jirovecii pneumonia (PCP) incidence in HIV-
infected patients after the introduction of antiretroviral therapy (ART) in resource-rich settings …

Objective This study aimed to evaluate the safety of avacopan, an orally administered C5a
receptor inhibitor, for the treatment of antineutrophil cytoplasmic antibody (ANCA) …

Background Current guidelines advise that rituximab or cyclophosphamide should be used
for the treatment of organ-threatening disease in anti-neutrophil cytoplasm antibody (ANCA) …

Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) comprises
granulomatosis with polyangiitis (GPA), microscopic polyangiitis (MPA) and eosinophilic …

The vasculitides are a heterogeneous group of conditions typified by their ability to cause
vessel inflammation with or without necrosis. They present with a wide variety of signs and …

Pulmonary complications in CTD are common and can involve the interstitium, airways,
pleura and pulmonary vasculature. ILD can occur in all CTD (CTD‐ILD), and may vary from …

Background Rituximab is often used as rescue therapy in interstitial lung disease (ILD)
associated with connective tissue disease (CTD), but has not been studied in clinical trials …